Skip to main content
Xiaoming Jia, MD, Neurology, South San Francisco, CA

XiaomingJiaMD

Neurology South San Francisco, CA

Neuroimmunology/Multiple Sclerosis

Medical Director, Biomarker Development, Genentech

Dr. Jia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jia's full profile

Already have an account?

  • Office

    1 DNA Way
    Office 421120
    South San Francisco, CA 94080

Summary

  • I am a board certified neurologist with fellowship training in neuroimmunology. I currently work in biomarker development and precision health at Genentech. I'm looking for a part-time (half to one day per week) clinical role in general / MS neurology in the SF Bay Area.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Neuroimmunology & Multiple Sclerosis, 2016 - 2019
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Neurology, 2013 - 2016
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2012 - 2013
  • Harvard Medical School
    Harvard Medical SchoolClass of 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2025
  • MA State Medical License
    MA State Medical License 2012 - 2013
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Abstracts/Posters

  • [Board 424] High-Sensitivity Troponin I and Incident Global Cardiovascular Events in a Community-Based Cohort: Atherosclerosis Risk in Communities (ARIC) Study
    Xiaoming Jia, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

  • Audience ARS Question: Top 3 Presentations in Dyslipidemia Most Likely to Impact or Change Clinical Practice or Future Research Agenda 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019